GPR91: Expanding the frontiers of Krebs cycle intermediates

Cell Communication and Signaling

Volumn 14, Issue 1, 2016, Pages

  De Castro Fonseca, Matheus ^a   Aguiar, Carla J ^b   Da Rocha Franco, Joao Antônio ^a   Gingold, Rafael N ^a   Leite, M Fatima ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Centro Universitário Estácio de Sá   (Brazil)

Author keywords

Cell functions; Cell signaling; GPR91; Succinate

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 91; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; SUCCINIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN; GPR91 PROTEIN, HUMAN;

BLOOD PRESSURE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CITRIC ACID CYCLE; FIBROGENESIS; HEART VENTRICLE HYPERTROPHY; HUMAN; LIVER; LIVER FIBROSIS; LIVER TRANSPLANTATION; MEAN ARTERIAL PRESSURE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA; RETINA NEOVASCULARIZATION; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; CARDIAC MUSCLE; GENE EXPRESSION; GENETICS; MOLECULAR MODEL;

ANIMALS; BLOOD PRESSURE; CITRIC ACID CYCLE; GENE EXPRESSION; HUMANS; LIVER; MODELS, MOLECULAR; MYOCARDIUM; RECEPTORS, G-PROTEIN-COUPLED; RETINA; SIGNAL TRANSDUCTION; SUCCINIC ACID;

EID: 84954144488     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-016-0126-1     Document Type: Review

References (35)

1. Thunberg T. Zur Kenntnis des intermediären Stoffwechsels und der dabei wirksamen. Enzyme Skandinavisches Archiv für Physiologie. 1920;40:1-91.
2. Annan G, Banga I, Blazsó A, Bruckner V, Laki K, Straub B, et al. Über die Bedeutung der Fumarsäure für die tierische Gewebeatmung. Einleitung, übersicht, Methoden Hoppe-Seyler's Zeitschrift für Physiologische Chemie. 1935;236:1-20.
3. Krebs HA, Johson WA. The role of citric acid in intermediate metabolism in animal tissues. Enzymologia. 1937;4:148-56.
4. Krebs HA. The history of the tricarboxylic acid cyle. Perspect Biol Med. 1970;14:154-70.
5. Fedotcheva NI, Sokolov AP, Kondrashova MN. Nonenzymatic formation of succinate in mitochondria under oxidative stress. Free Radic Biol Med. 2006;41:56-64.
6. Brosnan JT, Krebs HA, Williamson DH. Effects of Ischaemia on Metabolite Concentrations in Rat Liver. Biochent J. 1970;117:91-6.
7. Taegtmeyer H. Metabolic responses to cardiac hypoxia. Increased production of succinate by rabbit papillary muscles. Circ Res. 1978;43:808-15.
8. Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431-5.
9. Knauf F, Rogina B, Jiang Z, Aronson PS, Helfand SL. Functional characterization and immunolocalization of the transporter encoded by the life-extending gene Indy. Proc Natl Acad Sci U S A. 2002;99:14315-9.
10. Inoue K, Fei YJ, Zhuang L, Gopal E, Miyauchi S, Ganapathy V. Functional features and genomic organization of mouse NaCT, a sodium-coupled transporter for tricarboxylic acid cycle intermediates. Biochem J. 2004;378:949-57.
11. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 2004;429(6988):188-93.
12. Ariza AC, Deen PM, Robben JH. The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Front Endocrinol. 2012;00022:1664-2392.
13. Bhuniya D, Umrani D, Dave B, Salunke D, Kukreja G, Gundu J, et al. Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg Med Chem Lett. 2011;21(12):3596-602.
14. Hakak Y, Lehmann-Bruinsma K, Phillips S, Le T, Liaw C, Connolly DT, et al. The role of the GPR91 ligand succinate in hematopoiesis. J Leukoc Biol. 2009;85:837-43.
15. Aguiar CJ, Rocha-Franco JA, Sousa PA, Santos AK, Ladeira M, Rocha-Resende C, et al. Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation. Cell Commun Signal. 2014;12(1):78.
16. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest. 2008;118:2526-34.
17. Vargas SL, Toma I, Kang JJ, Meer EJ, Peti-Peterdi J. Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J Am Soc Nephrol. 2009;20(5):1002-11.
18. Robben JH, Fenton RA, Vargas SL, Schweer H, Peti-Peterdi J, Deen PM, et al. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int. 2009;76(12):1258-67.
19. Correa PRAV, Krulog EA, Thompsom M, Leite MF, Dranoff JA, Nathanson M. Succinate is a paracrine signal for liver damage. J Hepatology. 2007;47:262-9.
20. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14(10):1067-76.
21. Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido- Perrig N, et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol. 2008;9:1261-9.
22. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood. 2007;109:3260-9.
23. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275(4):2247-50.
24. Li YH, Woo SH, Choi DH, Cho EH. Succinate causes a-SMA production through GPR91 activation in hepatic stellate cells. Biochem Biophys Res Commun. 2015;463:853-8.
25. Adair TH, Gay WJ, Montani JP. Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol. 1990;259:393-404.
26. Folbergrova J, Ljunggren B, Norberg K, Siesjo BK. Influence of complete ischemia on glycolytic metabolites, citric acid cycle intermediates, and associated amino acids in the rat cerebral cortex. Brain Res. 1974;80:265-79.
27. Hoyer S, Krier C. Ischemia and aging brain. Studies on glucose and energy metabolism in rat cerebral cortex. Neurobiol Aging. 1986;7:23-9.
28. Joyal JS, Sitaras N, Binet F, Rivera JC, Stahl A, Zaniolo K, et al. Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood. 2011;117:6024-35.
29. Hu J, Wu Q, Li T, Chen Y, Wang S. Inhibition of high glucose-induced VEGF release in retinal ganglion cells by RNA interference targeting G protein-coupled receptor 91. Exp Eye Res. 2013;109:31-9.
30. Hu J, Li T, Du S, Chen Y, Wang S, Xiong F, et al. The MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells. Int J Mol Med. 2015;36(1):130-8.
31. Sadagopan N, Li W, Roberds SL, Major T, Preston GM, Yu Y, et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens. 2007;20(11):1209-15.
32. McCreath KJ, Espada S, Gálvez BG, Benito M, de Molina A, Sepúlveda P, et al. Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity. Diabetes. 2015;64(4):1154-67.
33. Aguiar CJ, Andrade VL, Gomes ER, Alves MN, Ladeira MS, Pinheiro AC, et al. Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium. 2010;47(1):37-46.
34. Zucker AR, Gondolesi GE, Abbott MA, Decker R, Rosengren SS, Fishbein TM. Liver-intestine transplant from a pediatric donor with unrecognized mitochondrial succinate cytochrome C reductase deficiency. Transplantation. 2005;79(3):356-8.
35. Davili Z, Johar S, Hughes C, Kveselis D, Hoo J. Succinate dehydrogenase deficiency associated with dilated cardiomyopathy and ventricular noncompaction. Eur J Pediatr. 2007;166:867-70.